• Home
  • About us
    • Our history
    • Our team
  • Science
    • Neuroprotection
    • Immune Modulation
    • Clinical Trials
  • Partners
  • Newsroom

Our partners

  • Corporate partners
  • Scientific partners
  • Public funding

Corporate partners

This company is capitalized by Innvierte, an investment program of CDTI (Spanish Ministry for Science and Innovation)

Scientific partners

Bellvitge Biomedical Research Institute (IDIBELL)

Cajal Institute (IC-CSIC)

Complutense University of Madrid - School of Medicine

Francisco de Vitoria University

Germans Trias i Pujol Research Institute (IGTP)

Girona Biomedical Research Institute (IDIBGI)

Health Research Institute of the Hospital Clínico San Carlos (IdISSC)

Institute of Biomedical Research Alberto Sols (IIBM – CSIC)

FISEVI

Institute of Health and Biomedical Research of Alicante (ISABIAL)

La Fe University Hospital

La Princesa University Hospital

Ramón y Cajal Health Research Institute (IRYCIS)

Vall d'Hebron Research Institute (VHIR)

Public funding

EIC Accelerator

Programa Neotec
Programa PID
Programa Cervera

Programa Retos-Colaboración Programa Torres Quevedo

Programa Cheque Innovación 2023

Programa Doctorados Industriales

Sello Excelencia 2023

Programa Misiones Ciencia e Innovación (Plan Estatal I+D+I)

Programa Retos-Colaboración 2021 (Proyecto TollMark) Programa Torres Quevedo

Líneas Enisa 2021

Aptatargets
Copyright © 2020 AptaTargets SL. All Right Reserved.
  • Home
  • Contact Us
  • Cookies policy
  • Legal notice
We use our own and third-party cookies to improve our services and show commercials related to your own preferences through the analysis of your browsing habits. Clicking Accept entails your acceptance in using them.
You can change this configuration or obtain additional information on legal warning.
ACCEPT